Thrombotic complications affect 3-10% of patients after liver transplantation (LT), leading to potentially life-threatening complications. In the days following LT, antithrombin (AT) is decreased longer than pro-coagulant factors, thus favouring a pro-thrombotic profile. Plasma transfusions are given empirically in some centres to correct AT levels following LT. We assessed the effect of plasma transfusion on AT levels after paediatric LT
Little is known about the role of platelets in relation to ischemia/reperfusion injury (IRI) of the ...
End-stage liver disease is characterized by multiple and complex alterations of hemostasis that are ...
Transient thrombocytopenia is a common phenomenon after liver transplantation. After liver transplan...
In adults with end-stage liver disease concurrent changes in pro- and antihemostatic pathways result...
BACKGROUND: Hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT) are serious causes of ...
BACKGROUND: Plasma transfusion remains the mainstay hemostatic therapy during liver transplantation ...
Traditionally, perioperative bleeding complications were a major concern during orthotopic liver tra...
Background & Aims: Patients with liver disease often show substantial changes in their hemostati...
Thrombosis is a major postoperative complication in pediatric liver transplantation. There is marked...
Intraoperative transfusion of red blood cells (RBC) is associated with adverse outcome after LT in a...
Background and Aims Patients with liver disease acquire complex changes in their hemostatic system, ...
Introduction. Recent studies have indicated an increased incidence of thrombotic vascular complicati...
Plasma levels of coagulation factors differ profoundly between adults and children, but are remarkab...
Recipient outcomes after pediatric liver transplantation improved significantly over the years. Two ...
In adults with end-stage liver disease concurrent changes in pro- and antihemostatic pathways result...
Little is known about the role of platelets in relation to ischemia/reperfusion injury (IRI) of the ...
End-stage liver disease is characterized by multiple and complex alterations of hemostasis that are ...
Transient thrombocytopenia is a common phenomenon after liver transplantation. After liver transplan...
In adults with end-stage liver disease concurrent changes in pro- and antihemostatic pathways result...
BACKGROUND: Hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT) are serious causes of ...
BACKGROUND: Plasma transfusion remains the mainstay hemostatic therapy during liver transplantation ...
Traditionally, perioperative bleeding complications were a major concern during orthotopic liver tra...
Background & Aims: Patients with liver disease often show substantial changes in their hemostati...
Thrombosis is a major postoperative complication in pediatric liver transplantation. There is marked...
Intraoperative transfusion of red blood cells (RBC) is associated with adverse outcome after LT in a...
Background and Aims Patients with liver disease acquire complex changes in their hemostatic system, ...
Introduction. Recent studies have indicated an increased incidence of thrombotic vascular complicati...
Plasma levels of coagulation factors differ profoundly between adults and children, but are remarkab...
Recipient outcomes after pediatric liver transplantation improved significantly over the years. Two ...
In adults with end-stage liver disease concurrent changes in pro- and antihemostatic pathways result...
Little is known about the role of platelets in relation to ischemia/reperfusion injury (IRI) of the ...
End-stage liver disease is characterized by multiple and complex alterations of hemostasis that are ...
Transient thrombocytopenia is a common phenomenon after liver transplantation. After liver transplan...